Peptide Legal Status in Idaho
Minimal restrictions beyond federal guidelines. Idaho has limited state-level pharmaceutical regulation beyond federal requirements. Research chemical sales and compounding pharmacies operate with standard federal oversight only.
Key Facts
Idaho Regulatory Details
Peptide Availability in Idaho
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Accessible |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Accessible |
| GHK-Cu | Not Approved | B | Accessible |
| Ipamorelin | Not Approved | B | Accessible |
| CJC-1295 | Not Approved | B | Accessible |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Accessible |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Accessible |
| Epithalon (Epitalon) | Not Approved | C | Accessible |
| Selank | Not Approved | B | Accessible |
| Semax | Not Approved | B | Accessible |
| GHRP-2 | Not Approved | B | Accessible |
| GHRP-6 | Not Approved | B | Accessible |
| Hexarelin | Not Approved | B | Accessible |
| Melanotan II | Not Approved | C | Accessible |
| LL-37 | Not Approved | C | Accessible |
| Thymalin | Not Approved | C | Accessible |
| KPV | Not Approved | D | Accessible |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Accessible |
| Survodutide | Not Approved | B | Accessible |
Peptides in Idaho: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.